Boji Medical Technology Co.,Ltd. (SHE:300404)
China · Delayed Price · Currency is CNY 12.10
+0.21 (1.77%)
Nov 5, 2026, 4:00 PM EST
Boji Medical Technology Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,016 | 868.64 | 742.02 | 555.83 | 423.68 | 324.2 |
Revenue Growth | 31.93% | 17.07% | 33.50% | 31.19% | 30.69% | 24.47% |
Gross Profit Gross Profit Growth | 244.21 | 232.23 | 224.04 | 182.49 | 156.11 | 138.64 |
Operating Income Operating Income Growth | 26.8 | 17.5 | 10 | -0.07 | 6.06 | 29.22 |
Net Income Net Income Growth | 57.88 | 30.49 | 28.78 | 24.34 | 27.67 | 38.88 |
Earnings Per Share EPS Growth | 0.15 | 0.08 | 0.08 | 0.07 | 0.08 | 0.11 |
EPS Growth | 676.72% | 5.58% | 14.63% | -12.88% | -32.34% | 108.04% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Clinical Research Services Clinical Research Services Growth | 714.06 | 597.38 | 414.51 | 277.12 | 199.9 |
Preclinical Research Service Preclinical Research Service Growth | 85.45 | 84.32 | 78.29 | 73.73 | 66.06 |
Independent R&D and Technology Transfer Services Independent R&D and Technology Transfer Services Growth | 9.27 | - | 0.25 | 11.43 | 12 |
Other Consulting Services Other Consulting Services Growth | 42.39 | 42.22 | 48.54 | 40.77 | 36.7 |
Unallocated Income from Other Operations Unallocated Income from Other Operations Growth | 17.46 | 18.1 | 14.24 | 12.62 | 9.55 |
Total Total Growth | 868.64 | 742.02 | 555.83 | 423.68 | 324.2 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 367.29 | 381.58 | 293.81 | 404.54 | 352.62 | 404.52 |
Total Debt Total Debt Growth | 40.09 | 43.79 | 46.13 | 111.62 | 80.84 | 31.5 |
Net Cash (Debt) Net Cash Growth | 327.2 | 337.78 | 247.68 | 292.92 | 271.78 | 373.02 |
Net Cash Growth | 23.82% | 36.38% | -15.44% | 7.78% | -27.14% | 194.69% |
Net Cash Per Share Net Cash Per Share Growth | 0.85 | 0.88 | 0.65 | 0.79 | 0.74 | 1.07 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 69.65 | 87.01 | 26.78 | 35.95 | 28.14 | 30.1 |
Capital Expenditures CapEx Growth | -21.17 | -18.71 | -29.35 | -62.2 | -117.73 | -53.99 |
Free Cash Flow Free Cash Flow Growth | 48.49 | 68.3 | -2.57 | -26.24 | -89.59 | -23.89 |
Free Cash Flow Growth | 53.17% | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 24.03% | 26.73% | 30.19% | 32.83% | 36.85% | 42.77% |
Operating Margin | 2.64% | 2.02% | 1.35% | -0.01% | 1.43% | 9.01% |
Pretax Margin | 6.01% | 3.46% | 2.48% | 3.17% | 5.80% | 14.52% |
Profit Margin | 5.70% | 3.51% | 3.88% | 4.38% | 6.53% | 11.99% |
FCF Margin | 4.77% | 7.86% | -0.35% | -4.72% | -21.15% | -7.37% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.013 | 0.013 | 0.012 | 0.010 | 0.010 | 0.014 |
Dividend Per Share Growth | 8.33% | 8.33% | 20.00% | 0% | -30.07% | - |
Dividend Yield | 0.11% | 0.14% | 0.14% | 0.11% | 0.13% | 0.14% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 80.60 | 117.20 | 115.17 | 140.46 | 104.10 | 92.99 |
Forward PE | - | 35.89 | 39.68 | 57.74 | - | - |
P/FCF Ratio | 95.60 | 52.33 | - | - | - | - |
PS Ratio | 4.56 | 4.11 | 4.47 | 6.15 | 6.80 | 11.15 |